Developer docs
API playgroundTry for free, no card

Search company profiles

Maxivision Super Speciality Eye Hospitals

Full company profile

uuid0002svd

Namestring
Maxivision Super Speciality Eye Hospitals
Legal namestring
Maxivision Super Speciality Eye Hospitals
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Maxivision Super Speciality Eye Hospitals is an Indian multi-specialty eye care chain founded in 1996 by Dr. Kasu Prasad Reddy in Hyderabad, and now co-led with healthcare entrepreneur Dr. G.S.K. Velu (founder of Trivitron Healthcare and Neuberg Diagnostics). The company operates a hub-and-spoke network of hospitals across six Indian states — Telangana, Andhra Pradesh, Gujarat, Tamil Nadu, Kerala, and Maharashtra — staffed by 250+ ophthalmologists under a doctor-partnership model that aligns physician ownership with network expansion. The chain offers the full ophthalmology stack: refractive surgery (LASIK, Contoura Vision, SMILE, SMILE PRO, SILK, PRK), cataract surgery (including Phacoemulsification), corneal transplantation (PDEK, Keratoplasty, Keratoconus management), retina care, glaucoma management, oculoplasty, dry eye, uveitis, and pediatric ophthalmology through the Little Eyes sub-brand. Clinical technology is procedure-led, drawing on third-party advanced surgical platforms (femtosecond lasers, ICL, OCT imaging, intravitreal injection protocols) rather than proprietary technology. The company has treated 5M+ patients cumulatively over 30+ years.

The business operates a patient-pay B2C model with quote-based, pay-as-you-go pricing for consultations and surgical procedures determined post-consultation. Revenue streams comprise outpatient consultations, surgical procedures, in-hospital optical retail (Maxivision Opticals selling eyewear and contact lenses), and ancillary professional services; corporate and insurance-covered patients form a secondary segment. Distribution is sales-led and field-driven via direct hospital presence, supplemented by self-serve online appointment booking and community engagement through medical camps and fellowship programs. Marketing relies on content/SEO, organic social, and PR/earned media rather than paid acquisition.

Maxivision has raised ~₹2,240 crore (~$270M) across two recent rounds — ₹1,300 crore from Quadria Capital in 2023 and ₹940 crore from Kotak Alternate Asset Managers in 2025 as pre-IPO funding — with capital earmarked for tier-II/III market penetration and western India expansion. The chain is one of India's top four eye care providers and is preparing for a public listing, targeting a position as the country's third-largest eye care chain via organic growth and acquisitions in underpenetrated geographies.

Short descriptiontext

Maxivision Super Speciality Eye Hospitals is an Indian multi-specialty eye care chain operating 50+ hospitals across 6 states with 250+ doctors under a doctor-partnership model, offering refractive, cataract, retinal, glaucoma, corneal, and pediatric ophthalmology services, backed by Quadria Capital and Kotak.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBegampet, India
HQ citystring
Begampet
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmology services, eye care hospitals, cataract surgery, refractive surgery, pediatric ophthalmology
Industry5 codes
1Ophthalmic Specialty Hospitals
CodeHLAFAHAJPrimaryYes
2Ophthalmology Clinics (Medical & Surgical Eye Care)
CodeHLAKAKACPrimaryNo
3Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery)
CodeHLAKAKAOPrimaryNo
4Ophthalmology Surgery Centers
CodeHLAFAIAFPrimaryNo
5Optometry Clinics (Primary Eye Care)
CodeHLAKAKABPrimaryNo
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Offices of Optometrists62132
  • Optical Goods Retailers45613
SIC code3 codes
  • Services-Hospitals8060
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Ophthalmic Goods3851
Product category
Eye Care Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Outpatient Consultations
TypeOne Time License
Description

Revenue from eye care consultations and diagnostic services at hospital facilities across 6 states

2Surgical Procedures
TypeOne Time License
Description

Revenue from advanced surgical procedures including cataract, refractive, cornea, retina, and glaucoma surgeries

3Optical Retail Sales
TypeHardware Sales
Description

Revenue from Maxivision Opticals retail division selling eyeglasses, contact lenses, and optical products

4Healthcare Services
TypeProfessional Services
Description

Comprehensive eye care service fees including pediatric eye care (Little Eyes) and general ophthalmology

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Quote-based surgical and diagnostic services
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing determined after consultation based on procedure type and patient requirements. Not publicly disclosed on website.

GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Little Eyes
Description

Paediatric eye care services for children

maxivisioneyehospital.com
Core offering1 text field

Maxivision Super Speciality Eye Hospitals operates a network of eye hospitals across 6 Indian states providing comprehensive ophthalmology services, including cataract surgery, advanced refractive surgery (LASIK, SMILE, SMILE PRO, SILK, Contoura Vision, PRK), corneal transplantation, retinal care, glaucoma management, pediatric eye care (Little Eyes sub-brand), oculoplasty, and an in-house optical retail division. Care is delivered under a doctor-partnership model with 250+ specialist doctors supported by advanced diagnostic and surgical ophthalmic technology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 5 million+ patients treated over 30+ years of operation
+1 more record
Product overview1 text field

Maxivision Super Speciality Eye Hospitals operates a network of 250+ eye hospitals across 6 Indian states (Telangana, Tamil Nadu, Andhra Pradesh, Kerala, Gujarat, Maharashtra) under a doctor-partnership model. Founded in 1996 by Dr. Kasu Prasad Reddy and later joined by Dr. G.S.K. Velu, the hospital offers comprehensive eye care services organized around core specialty areas: Refractive Surgery (LASIK, Contoura Vision, SMILE, SMILE PRO, SILK, PRK), Cataract Surgery, Corneal Services (PDEK, Keratoplasty, Keratoconus), Paediatric Ophthalmology (Little Eyes sub-brand), Retina Care, Glaucoma, Oculoplasty, and General Ophthalmology. The network provides the full spectrum of eye care from routine exams to advanced surgical procedures, supported by diagnostic imaging technologies. The company follows a hub-and-spoke model with partner hospitals including Sharat Maxivision, Ojas Maxivision, SRG Eye Hospital, and others across regions.

Product and service19 records
1Cataract Surgery
CategoryOphthalmic Surgery
Description

Surgical removal of the clouded lens and replacement with an artificial intraocular lens to restore vision, performed using phacoemulsification across Maxivision's hospital network.

2LASIK Treatment
CategoryRefractive Surgery
Description

Laser-Assisted in Situ Keratomileusis procedure that reshapes the cornea using a microkeratome or femtosecond laser flap to correct refractive errors.

3Contoura Vision Treatment
CategoryRefractive Surgery
Description

Topography-guided LASIK that uses corneal topography data to customize laser treatment, addressing refractive errors and corneal irregularities for sharper vision.

4SMILE (Small Incision Lenticule Extraction)
CategoryRefractive Surgery
Description

Minimally invasive lenticule extraction vision correction performed through a 2-4mm incision without creating a corneal flap, preserving corneal strength with reduced dryness.

5SMILE PRO
CategoryRefractive Surgery
Description

Upgraded version of SMILE using advanced femtosecond lasers for faster cutting times and improved precision, enabling shorter procedures and quicker recovery.

6SILK (Smooth Incision Lenticule Keratomileusis)
CategoryRefractive Surgery
Description

Next-generation lenticule extraction using ultra-fast lasers and ultra-smooth incisions for higher precision, comfort, and visual outcomes in refractive correction.

7Photorefractive Keratectomy (PRK)
CategoryRefractive Surgery
Description

First-generation laser eye surgery technique that gently removes the outer corneal layer before laser reshaping, suitable for patients with thinner corneas.

8Pre-Descemet's Endothelial Keratoplasty (PDEK)
CategoryCornea Services
Description

Advanced corneal transplantation technique that replaces the endothelial layer with quicker recovery compared to traditional penetrating keratoplasty.

9Corneal Transplantation (Keratoplasty)
CategoryCornea Services
Description

Surgical procedure to replace damaged or diseased cornea with healthy donor tissue in order to restore vision.

10Keratoconus Treatment
CategoryCornea Services
Description

Treatment for progressive thinning and cone-shaped protrusion of the cornea using therapeutic approaches including collagen cross-linking.

11Glaucoma Treatment
CategoryOphthalmic Surgery
Description

Comprehensive glaucoma management including prescription eye drops, oral medications, laser therapy, Trabeculectomy microsurgery, and Minimally Invasive Glaucoma Surgery (MIGS).

12Paediatric Eye Care (Little Eyes)
CategoryPediatric Ophthalmology
Description

Specialized child-friendly sub-brand offering comprehensive pediatric eye exams, vision therapy, and treatment for conditions such as squint, lazy eye, childhood cataracts, and pediatric refractive errors.

13Squint Surgery
CategoryPediatric Ophthalmology
Description

Surgical correction of eye misalignment (strabismus) involving weakening, strengthening, or vector adjustment procedures on the extraocular muscles.

14Retina Care Services
CategoryRetina Services
Description

Comprehensive retinal disease management including treatment for diabetic retinopathy, retinal detachment, macular hole, macular edema, and retinopathy of prematurity using intravitreal injections, laser therapy, and vitrectomy.

15Glued Intraocular Lens (IOL) Surgery
CategoryOphthalmic Surgery
Description

Surgical technique using biological glue derived from human blood plasma to secure a posterior chamber IOL in eyes with deficient or absent posterior capsule.

16Oculoplasty & Aesthetic Eye Surgery
CategoryOphthalmic Surgery
Description

Surgical and non-surgical procedures for the eyelids, orbit, and lacrimal system, including ptosis repair, blepharoplasty, and cosmetic eye treatments.

17Dry Eyes Treatment
CategoryGeneral Ophthalmology
Description

Management of dry eye syndrome using artificial tears, prescription medications, punctal plugs, and lifestyle modifications.

18Uveitis Treatment
CategoryGeneral Ophthalmology
Description

Treatment of uvea inflammation including anti-inflammatory medications, immunosuppressive drugs, biologic therapies, and surgery for complications.

19Maxivision Opticals
CategoryOptical Retail
Description

Optical retail service offering prescription glasses, frames, contact lenses, and eyewear accessories at Maxivision hospital locations.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pan-Indian specialty eye hospital chain operating a hub-and-spoke model across 100+ centers, offering cataract, refractive, retina, and cornea services — the most direct competitor to Maxivision in scale, scope, and PE-backed growth strategy.

TypeDirect peer
Description

Large Indian eye care chain with multi-specialty ophthalmology services (cataract, LASIK, retina, glaucoma, oculoplasty) across 80+ centers; directly comparable as a specialty-only, multi-state eye hospital network.

TypeDirect peer
Description

PE-backed Indian eye hospital chain (backed by Foundation Holdings and others) with 60+ centers offering comprehensive ophthalmology — closely comparable specialty hospital model with similar expansion-driven growth trajectory.

TypeDirect peer
Description

One of India's largest eye care networks with multi-state presence and a similar full-spectrum ophthalmology service portfolio; a direct comparator despite recent operational and ownership challenges.

TypeDirect peer
Description

Multi-specialty Indian eye hospital chain with a tier-II/III-focused expansion strategy similar to Maxivision's, offering cataract, refractive, and retina services — comparable in geography targeting and unit-level model.

TypeBroad incumbent
Description

Premier Indian ophthalmology institution offering tertiary eye care, training, and research across multiple centers; a broader incumbent benchmark for clinical depth and academic reputation rather than commercial scale.

TypeBroad incumbent
Description

Renowned non-profit Indian eye hospital known for super-specialty ophthalmology and high surgical volumes; comparable on clinical breadth and brand authority, though not a for-profit commercial peer.

TypeBroad incumbent
Description

Large multi-specialty Indian hospital chain with ophthalmology departments; competes for the same patient pool in tier-I/II cities but offers broader clinical services rather than eye-care specialization.

TypeBroad incumbent
Description

India's largest hospital network with ophthalmology as one of many specialties; sets the benchmark for multi-specialty healthcare delivery but is broader and less specialized than Maxivision.

TypeOthers
Description

Largest organized optical retail chain in India selling frames, lenses, and contact lenses; comparable to Maxivision Opticals on the eyewear retail layer rather than surgical eye care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Maxivision Super Speciality Eye Hospitals

Eye Care Servicesmaxivisioneyehospital.com

Maxivision Super Speciality Eye Hospitals is an Indian multi-specialty eye care chain operating 50+ hospitals across 6 states with 250+ doctors under a doctor-partnership model, offering refractive, cataract, retinal, glaucoma, corneal, and pediatric ophthalmology services, backed by Quadria Capital and Kotak.

What Maxivision Super Speciality Eye Hospitals does

Maxivision Super Speciality Eye Hospitals is an Indian multi-specialty eye care chain founded in 1996 by Dr. Kasu Prasad Reddy in Hyderabad, and now co-led with healthcare entrepreneur Dr. G.S.K. Velu (founder of Trivitron Healthcare and Neuberg Diagnostics). The company operates a hub-and-spoke network of hospitals across six Indian states — Telangana, Andhra Pradesh, Gujarat, Tamil Nadu, Kerala, and Maharashtra — staffed by 250+ ophthalmologists under a doctor-partnership model that aligns physician ownership with network expansion. The chain offers the full ophthalmology stack: refractive surgery (LASIK, Contoura Vision, SMILE, SMILE PRO, SILK, PRK), cataract surgery (including Phacoemulsification), corneal transplantation (PDEK, Keratoplasty, Keratoconus management), retina care, glaucoma management, oculoplasty, dry eye, uveitis, and pediatric ophthalmology through the Little Eyes sub-brand. Clinical technology is procedure-led, drawing on third-party advanced surgical platforms (femtosecond lasers, ICL, OCT imaging, intravitreal injection protocols) rather than proprietary technology. The company has treated 5M+ patients cumulatively over 30+ years.

The business operates a patient-pay B2C model with quote-based, pay-as-you-go pricing for consultations and surgical procedures determined post-consultation. Revenue streams comprise outpatient consultations, surgical procedures, in-hospital optical retail (Maxivision Opticals selling eyewear and contact lenses), and ancillary professional services; corporate and insurance-covered patients form a secondary segment. Distribution is sales-led and field-driven via direct hospital presence, supplemented by self-serve online appointment booking and community engagement through medical camps and fellowship programs. Marketing relies on content/SEO, organic social, and PR/earned media rather than paid acquisition.

Maxivision has raised ~₹2,240 crore (~$270M) across two recent rounds — ₹1,300 crore from Quadria Capital in 2023 and ₹940 crore from Kotak Alternate Asset Managers in 2025 as pre-IPO funding — with capital earmarked for tier-II/III market penetration and western India expansion. The chain is one of India's top four eye care providers and is preparing for a public listing, targeting a position as the country's third-largest eye care chain via organic growth and acquisitions in underpenetrated geographies.

Maxivision Super Speciality Eye Hospitals firmographics

Firmographics
Name
Maxivision Super Speciality Eye Hospitals
Legal name
Maxivision Super Speciality Eye Hospitals
Website
https://www.maxivisioneyehospital.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
251–500 employees
Short description
Maxivision Super Speciality Eye Hospitals is an Indian multi-specialty eye care chain operating 50+ hospitals across 6 states with 250+ doctors under a doctor-partnership model, offering refractive, cataract, retinal, glaucoma, corneal, and pediatric ophthalmology services, backed by Quadria Capital and Kotak.
Ownership category
akta.pro rank

Maxivision Super Speciality Eye Hospitals industry classification

Industry
Product category
Eye Care Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Optometrists (62132), Optical Goods Retailers (45613)
SIC
Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Ophthalmic Goods (3851)
akta.pro primary industry
Ophthalmic Specialty Hospitals (HLAFAHAJ)
akta.pro secondary industries
Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC), Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO), Ophthalmology Surgery Centers (HLAFAIAF), Optometry Clinics (Primary Eye Care) (HLAKAKAB)

Keywords

  • Ophthalmology services
  • Eye care hospitals
  • Cataract surgery
  • Refractive surgery
  • Pediatric ophthalmology

Where Maxivision Super Speciality Eye Hospitals is headquartered

Location

Headquarters

HQ city
Begampet
HQ country
India
HQ region
Asia

Offices7 records

Markets served

Maxivision Super Speciality Eye Hospitals business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Outpatient Consultations: Revenue from eye care consultations and diagnostic services at hospital facilities across 6 states
  2. Surgical Procedures: Revenue from advanced surgical procedures including cataract, refractive, cornea, retina, and glaucoma surgeries
  3. Optical Retail Sales: Revenue from Maxivision Opticals retail division selling eyeglasses, contact lenses, and optical products
  4. Healthcare Services: Comprehensive eye care service fees including pediatric eye care (Little Eyes) and general ophthalmology

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based surgical and diagnostic services

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Maxivision Super Speciality Eye Hospitals product offering

Product offering

Core offering

Maxivision Super Speciality Eye Hospitals operates a network of eye hospitals across 6 Indian states providing comprehensive ophthalmology services, including cataract surgery, advanced refractive surgery (LASIK, SMILE, SMILE PRO, SILK, Contoura Vision, PRK), corneal transplantation, retinal care, glaucoma management, pediatric eye care (Little Eyes sub-brand), oculoplasty, and an in-house optical retail division. Care is delivered under a doctor-partnership model with 250+ specialist doctors supported by advanced diagnostic and surgical ophthalmic technology.

Product overview

Maxivision Super Speciality Eye Hospitals operates a network of 250+ eye hospitals across 6 Indian states (Telangana, Tamil Nadu, Andhra Pradesh, Kerala, Gujarat, Maharashtra) under a doctor-partnership model. Founded in 1996 by Dr. Kasu Prasad Reddy and later joined by Dr. G.S.K. Velu, the hospital offers comprehensive eye care services organized around core specialty areas: Refractive Surgery (LASIK, Contoura Vision, SMILE, SMILE PRO, SILK, PRK), Cataract Surgery, Corneal Services (PDEK, Keratoplasty, Keratoconus), Paediatric Ophthalmology (Little Eyes sub-brand), Retina Care, Glaucoma, Oculoplasty, and General Ophthalmology. The network provides the full spectrum of eye care from routine exams to advanced surgical procedures, supported by diagnostic imaging technologies. The company follows a hub-and-spoke model with partner hospitals including Sharat Maxivision, Ojas Maxivision, SRG Eye Hospital, and others across regions.

Differentiator

Problem solved

Functional benefit

Brands

  • Little Eyes: Paediatric eye care services for children

Products and services

  • Cataract Surgery Surgical removal of the clouded lens and replacement with an artificial intraocular lens to restore vision, performed using phacoemulsification across Maxivision's hospital network.
  • LASIK Treatment Laser-Assisted in Situ Keratomileusis procedure that reshapes the cornea using a microkeratome or femtosecond laser flap to correct refractive errors.
  • Contoura Vision Treatment Topography-guided LASIK that uses corneal topography data to customize laser treatment, addressing refractive errors and corneal irregularities for sharper vision.
  • SMILE (Small Incision Lenticule Extraction) Minimally invasive lenticule extraction vision correction performed through a 2-4mm incision without creating a corneal flap, preserving corneal strength with reduced dryness.
  • SMILE PRO Upgraded version of SMILE using advanced femtosecond lasers for faster cutting times and improved precision, enabling shorter procedures and quicker recovery.
  • SILK (Smooth Incision Lenticule Keratomileusis) Next-generation lenticule extraction using ultra-fast lasers and ultra-smooth incisions for higher precision, comfort, and visual outcomes in refractive correction.
  • Photorefractive Keratectomy (PRK) First-generation laser eye surgery technique that gently removes the outer corneal layer before laser reshaping, suitable for patients with thinner corneas.
  • Pre-Descemet's Endothelial Keratoplasty (PDEK) Advanced corneal transplantation technique that replaces the endothelial layer with quicker recovery compared to traditional penetrating keratoplasty.
  • Corneal Transplantation (Keratoplasty) Surgical procedure to replace damaged or diseased cornea with healthy donor tissue in order to restore vision.
  • Keratoconus Treatment Treatment for progressive thinning and cone-shaped protrusion of the cornea using therapeutic approaches including collagen cross-linking.
  • Glaucoma Treatment Comprehensive glaucoma management including prescription eye drops, oral medications, laser therapy, Trabeculectomy microsurgery, and Minimally Invasive Glaucoma Surgery (MIGS).
  • Paediatric Eye Care (Little Eyes) Specialized child-friendly sub-brand offering comprehensive pediatric eye exams, vision therapy, and treatment for conditions such as squint, lazy eye, childhood cataracts, and pediatric refractive errors.
  • Squint Surgery Surgical correction of eye misalignment (strabismus) involving weakening, strengthening, or vector adjustment procedures on the extraocular muscles.
  • Retina Care Services Comprehensive retinal disease management including treatment for diabetic retinopathy, retinal detachment, macular hole, macular edema, and retinopathy of prematurity using intravitreal injections, laser therapy, and vitrectomy.
  • Glued Intraocular Lens (IOL) Surgery Surgical technique using biological glue derived from human blood plasma to secure a posterior chamber IOL in eyes with deficient or absent posterior capsule.
  • Oculoplasty & Aesthetic Eye Surgery Surgical and non-surgical procedures for the eyelids, orbit, and lacrimal system, including ptosis repair, blepharoplasty, and cosmetic eye treatments.
  • Dry Eyes Treatment Management of dry eye syndrome using artificial tears, prescription medications, punctal plugs, and lifestyle modifications.
  • Uveitis Treatment Treatment of uvea inflammation including anti-inflammatory medications, immunosuppressive drugs, biologic therapies, and surgery for complications.
  • Maxivision Opticals Optical retail service offering prescription glasses, frames, contact lenses, and eyewear accessories at Maxivision hospital locations.

Quantifiable outcome

  • 5 million+ patients treated over 30+ years of operation
  • +1 more outcomes

Companies that use Maxivision Super Speciality Eye Hospitals

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Maxivision Super Speciality Eye Hospitals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Maxivision Super Speciality Eye Hospitals partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Maxivision Super Speciality Eye Hospitals competitors and assessment

Company assessment

Direct peers

  • Dr. Agarwal's Eye Hospital: Pan-Indian specialty eye hospital chain operating a hub-and-spoke model across 100+ centers, offering cataract, refractive, retina, and cornea services — the most direct competitor to Maxivision in scale, scope, and PE-backed growth strategy.
  • Centre for Sight: Large Indian eye care chain with multi-specialty ophthalmology services (cataract, LASIK, retina, glaucoma, oculoplasty) across 80+ centers; directly comparable as a specialty-only, multi-state eye hospital network.
  • ASG Eye Hospitals: PE-backed Indian eye hospital chain (backed by Foundation Holdings and others) with 60+ centers offering comprehensive ophthalmology — closely comparable specialty hospital model with similar expansion-driven growth trajectory.
  • Vasan Eye Care: One of India's largest eye care networks with multi-state presence and a similar full-spectrum ophthalmology service portfolio; a direct comparator despite recent operational and ownership challenges.
  • Eye-Q Vision: Multi-specialty Indian eye hospital chain with a tier-II/III-focused expansion strategy similar to Maxivision's, offering cataract, refractive, and retina services — comparable in geography targeting and unit-level model.

Broad incumbents

  • L.V. Prasad Eye Institute: Premier Indian ophthalmology institution offering tertiary eye care, training, and research across multiple centers; a broader incumbent benchmark for clinical depth and academic reputation rather than commercial scale.
  • Sankara Nethralaya: Renowned non-profit Indian eye hospital known for super-specialty ophthalmology and high surgical volumes; comparable on clinical breadth and brand authority, though not a for-profit commercial peer.
  • Manipal Hospitals: Large multi-specialty Indian hospital chain with ophthalmology departments; competes for the same patient pool in tier-I/II cities but offers broader clinical services rather than eye-care specialization.
  • Apollo Hospitals: India's largest hospital network with ophthalmology as one of many specialties; sets the benchmark for multi-specialty healthcare delivery but is broader and less specialized than Maxivision.

Others

  • Titan Eye+: Largest organized optical retail chain in India selling frames, lenses, and contact lenses; comparable to Maxivision Opticals on the eyewear retail layer rather than surgical eye care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Maxivision Super Speciality Eye Hospitals social profiles

Digital presence

Maxivision Super Speciality Eye Hospitals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Maxivision Super Speciality Eye Hospitals leadership team

Management profile

Number of profiles

Profiles11 records

Maxivision Super Speciality Eye Hospitals subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Maxivision Super Speciality Eye Hospitals funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Maxivision Super Speciality Eye Hospitals M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maxivision Super Speciality Eye Hospitals

What does Maxivision Super Speciality Eye Hospitals do?

Maxivision Super Speciality Eye Hospitals operates a network of eye hospitals across 6 Indian states providing comprehensive ophthalmology services, including cataract surgery, advanced refractive surgery (LASIK, SMILE, SMILE PRO, SILK, Contoura Vision, PRK), corneal transplantation, retinal care, glaucoma management, pediatric eye care (Little Eyes sub-brand), oculoplasty, and an in-house optical retail division. Care is delivered under a doctor-partnership model with 250+ specialist doctors supported by advanced diagnostic and surgical ophthalmic technology.

Is Maxivision Super Speciality Eye Hospitals a public or private company?

Maxivision Super Speciality Eye Hospitals is a private company. It is classified as venture growth investor backed and is currently operating.

When was Maxivision Super Speciality Eye Hospitals founded?

Maxivision Super Speciality Eye Hospitals was founded in 1996. It employs 251 to 500 people.

Where is Maxivision Super Speciality Eye Hospitals based?

Maxivision Super Speciality Eye Hospitals is headquartered in Begampet, India, in the Asia region.

How does Maxivision Super Speciality Eye Hospitals make money?

Four revenue lines are on record. Outpatient Consultations are the primary driver. The others are surgical Procedures, optical Retail Sales and healthcare Services.

Who are Maxivision Super Speciality Eye Hospitals's main competitors?

Direct peers on record are Dr. Agarwal's Eye Hospital, Centre for Sight, ASG Eye Hospitals, Vasan Eye Care and Eye-Q Vision. Broad incumbents are L.V. Prasad Eye Institute, Sankara Nethralaya, Manipal Hospitals and Apollo Hospitals. Titan Eye+ is listed as an others.

Does Maxivision Super Speciality Eye Hospitals have an API?

No public API is recorded for Maxivision Super Speciality Eye Hospitals.

What industry is Maxivision Super Speciality Eye Hospitals in?

Maxivision Super Speciality Eye Hospitals's product category is Eye Care Services. Its primary akta.pro industry code is HLAFAHAJ, Ophthalmic Specialty Hospitals, with a secondary code of HLAKAKAC, Ophthalmology Clinics (Medical & Surgical Eye Care). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business News TodayMaxivision Eye Hospitals confidentially files for IPO, takes first formal step toward listing- Moneycontrol.comMaxivision Super Specialty Eye Hospitals, backed by Quadria Capital, confidentially filed for an IPO, with ICICI Securities and IIFL Capital as bankers. The chain operates over 90 centres across six states, and India's eye-care market is projected to grow to $31.2 billion by 2033.DealStreetAsiaQuadria-backed Maxivision confidentially files for India IPOMaxivision Super Specialty Eye Hospitals, backed by Quadria Capital, confidentially filed for an IPO in India. The eye-care chain operates over 90 centres across six states and competes with other chains. India's eye-care market is projected to grow to $31.2 billion by 2033.MedtechspectrumMaxivision Eye Hospital receives investment worth $155 M to drive organic expansionQuadria Capital, an Asia-focused private equity firm, has announced an investment of up to $155 million in Maxivision Eye Hospital, one of India's leading private eye care clinic chains. The investment comprises an initial $75 million for a significant minority stake plus up to $80 million for additional stake, representing one of the largest investments in the eye care services space. Maxivision, which operates 42 centers across five states in South and West India, will use the capital to drive organic expansion and pursue tuck-in acquisitions in underserved tier-2 and tier-3 cities.The HinduHospital’s five-year community eyecare drive helps over 10,000 children in TiruchiMaxivision Super Speciality Eye Hospitals in Tiruchi has completed five years of a community vision care initiative conducted in partnership with the Shiv Bhagat family, having screened over 10,000 students and provided more than 600 pairs of free eyewear to children from economically weaker sections. This year, the hospital screened over 2,250 students across three schools, with more than 150 deserving students set to receive prescription spectacles at no cost. The initiative aims to remove educational barriers by enabling children with vision problems to participate fully in classroom learning.The Times of IndiaMaxivision Super Specialty Eye Hospitals Plans $1 Billion IPO with Quadria Capital Backing, ETHealthworldMaxivision Super Specialty Eye Hospitals, backed by healthcare-focused buyout firm Quadria Capital, has appointed ICICI Securities and IIFL Capital as bankers for a planned 2027 initial public offering. The Hyderabad-based company operates more than 90 eye-care centres across six Indian states, competing with chains such as Dr. Agarwal's Health Care, Centre for Sight and ASG Eye Hospitals. The IPO will include a mix of newly-issued shares and stock sold by existing investors, with India's eye-care market projected to grow to $31.2 billion by 2033 from $12.8 billion in 2025.VCCircleQuadria-backed Maxivision hires bankers for IPOMaxivision Super Specialty Eye Hospitals, backed by Quadria Capital, has appointed ICICI Securities and IIFL Capital as bankers for a planned 2027 IPO. The Hyderabad-based company operates over 90 eye-care centres across six states. The IPO size has not been finalized.BusinessLineMaxivision Super Speciality Eye Hospitals appoints Badrinarayan Srikanth as Group CEOMaxivision Super Speciality Eye Hospitals has appointed Badrinarayan Srikanth as its Group Chief Executive Officer, transitioning him from his previous role as Group CFO. Srikanth's elevation comes as Maxivision continues to expand its eye care network, which currently includes over 90 facilities across six states in South and West India. The company stated that his focus will remain on strengthening clinical excellence, empowering doctors and employees, and creating greater value for patients and communities.MintG.S.K. Velu’s Maxivision eyes west India push ahead of listing next year | Company Business NewsG.S.K. Velu-backed Maxivision Super Specialty Eye Hospitals is planning a major expansion into western India, targeting 10+ hospitals in Mumbai and a broader presence across Maharashtra, Madhya Pradesh, and Chhattisgarh, as it prepares to launch its IPO process next year. The Hyderabad-based eyecare chain, currently among the top four in India, aims to become the third-largest by revenue before listing, with western India contributing 30-35% of its total revenue. Velu intends to take three of his healthcare ventures public over the next three years, starting with Neuberg Diagnostics, followed by Maxivision and Trivitron Healthcare, having raised ₹1,300 crore from Quadria Capital in 2023 and ₹940 crore from Kotak Alternate Asset Managers in 2025 for pre-IPO rounds.BusinessLineMaxivision Eye Hospitals plans Gujarat expansion; to invest Rs 150 cr in 2 yrsEye care chain Maxivision Super Speciality Eye Hospitals announced plans to double its Gujarat network from 10 to 20 hospitals over the next two years, backed by a Rs 150 crore investment. The Hyderabad-headquartered company has formed a partnership with Ahmedabad-based SRG Eye Hospital and aims to add five more hospitals in Ahmedabad alone while evaluating new locations such as Vapi and Vadodara. Maxivision, which follows a doctor-partnership model, is also planning to enter new markets including Karnataka, Goa, Madhya Pradesh, and Odisha within the year.BusinessLineMaxivision Super Speciality Eye Hospitals to invest ₹400 crore in Tamil Nadu in the next 2-3 yearsMaxivision Super Speciality Eye Hospitals announced plans to invest ₹400 crore in Tamil Nadu over the next 2–3 years, marking its entry into Chennai with 10 super specialty eye hospitals and vision centres, including ₹100 crore earmarked specifically for the city. The company, which raised approximately ₹1,300 crore from private equity firm Quadria Capital in 2023 and is targeting an IPO in 2027, currently generates around ₹700 crore in revenue and ranks third in revenue and second in profits among eye hospital chains in India. Maxivision, which already operates hospitals in cities like Trichy, Madurai, and Salem, aims to expand across all districts of Tamil Nadu and reach 100 hospitals and 100 vision centres nationwide by the end of the fiscal year.